IVD Tests focusing on respiratory disease diagnosis

The company has been bringing innovative products to the marketplace by developing customer-friendly rapid diagnostic tests.

The company's technological platforms reduce test performance complexity to a single step, making it simpler and more intuitive for the end user. It also improves the process of patient screening, shifting it from centralized labs to the point-of-care and self-use, thereby improving healthcare provision and HMO service quality.

Having identified the need for more user-friendly and accurate rapid diagnostic tests, the company has developed and pioneered a first-of-its-kind of No-Step IVD integrated diagnostic devices that include Strep A, COVID-19 Ag, and Influenza A+B tests that greatly simplify rapid diagnostic testing.

We also supply rapid tests for many additional infectious diseases, cardiac and cancer markers, fertility, urinalysis, drugs of abuse, and more.

Our company is constantly expanding its product line by improving its existing products and adding novel ones to its portfolio.

We are seeking importers and distributors in major territories for our current products.

Other Information: 
We take pride in participating in the ongoing point-of-care diagnostics revolution, making rapid tests more accurate and simpler to use and supporting the transition of diagnostic tests from central labs to the physicians’ offices and from there to patients’ homes.
We continuously strive to improve our products offering, paying close attention to our existing long-term customers’ needs and feedback. 

Potential Partners: Importers, Distributors, HMO's, Clinics, Hospitals.

Target Countries: Europe.

Company Info:

Year of Establishment: 2004  
No.   of Employees:      15